Conjoint Ophthalmology Scientific Conference (COSC 2017)
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Abstracts of the 16Th Annual Scientific Meeting of the College Of
Malaysian J Pathol 2018; 40(1) : 83 – 102 The 16th Annual Scientific Meeting of the College of Pathologists, Academy of Medicine of Malaysia was held at the Royale Chulan Seremban Hotel, in Seremban, Negeri Sembilan on 12th- 13th October 2017. Abstracts of paper (poster) presented are as follows: AP-01. A palatal swelling transpires out as a nasal B-cell NHL- a case report Sunil Pazhayanur Venkateswaran1, Rafiq Abdul Karim Vasiwala2 Department of Pathology1 and ENT2, International Medical University, Kuala Lumpur, Malaysia Introduction: Primary sinonasal Non-Hodgkin’s Lymphoma’s (NHLs) is a rare condition, which emulates the presentation of a benign inflammatory disease. It is challenging to distinguish morphologically as well as radiologically sinonasal lymphomas from other malignant neoplasms. Case Report: We report a 37-year-old male patient who was presented with nasal obstruction, rhinorrhoea, bloody discharge/epistaxis, post nasal drip, facial swelling, orbital symptoms and fever. Endoscopic examination and CT scan of the paranasal sinuses with adequate amount of biopsy tissue is required for a definitive diagnosis. Considering this, endoscopic sinus surgery was performed to eradicate the disease as well as obtain a definite histological diagnosis. The mass was histologically proven as a Nasal diffuse large B-cell lymphoma(DLBCL) and confirmed by immunohistochemistry. Immunohistochemically, the cells were strongly positive for CD20, CD79a, BCL2, BCL6 and MUM1.CD10 was focally positive. Ki-67 index was <99%. After confirmation of the histological diagnosis, chemotherapy was started and with the first cycle, the patient improved with resolution of the facial swelling as well as pain and visual defects. Conclusion: The diagnosis of a sinonasal lymphoma is a challenge for otorhinologists. -
Risk Factors Associated with Necrotising Enterocolitis in Very Low Birth Weight Infants in Malaysian Neonatal Intensive Care Units
O riginal A rticle Singapore Med J 2012; 53(12) : 826 Risk factors associated with necrotising enterocolitis in very low birth weight infants in Malaysian neonatal intensive care units Nem-Yun Boo1, MRCP, FRCPCH, Irene Guat Sim Cheah2, MRCP, FRCPCH; Malaysian National Neonatal Registry Introduction This study aimed to identify the risk factors associated with necrotising enterocolitis (NEC) in very low birth weight (VLBW; weight < 1,501 g) infants in Malaysian neonatal intensive care units (NICUs). Methods This was a retrospective study based on data collected in a standardised format for all VLBW infants born in 2007 (n = 3,601) and admitted to 31 NICUs in Malaysian public hospitals. A diagnosis of NEC was made based on clinical, radiological and/or histopathological evidence of stage II or III, according to Bell’s criteria. Logistic regression analysis was performed to determine the significant risk factors associated with NEC. ResuLts 222 (6.2%) infants developed NEC (stage II, n = 197; stage III, n = 25). 69 (31.3%) infants died (stage II, n = 58; stage III, n = 11). The significant risk factors associated with NEC were: maternal age (adjusted odds ratio [OR] 1.024, 95% confidence interval [CI] 1.003–1.046; p = 0.027), intrapartum antibiotics (OR 0.639, 95% CI 0.421–0.971; p = 0.036), birth weight (OR 0.999, 95% CI 0.998–0.999; p < 0.001), surfactant therapy (OR 1.590, 95% CI 1.170– 2.161; p = 0.003), congenital pneumonia (OR 2.00, 95% CI 1.405–2.848; p < 0.001) and indomethacin therapy for the closure of patent ductus arteriosus (PDA) (OR 1.821, 95% CI 1.349–2.431; p = 0.001). -
Selective Screening for Gestational Diabetes in Malaysia
Ganeshan Muniswaran1, H Suharjono1, SA Soelar2, SD Karalasingam2, R Jeganathan3 Sarawak General Hospital, 1-Sarawak General Hospital, Kuching, Sarawak, Malaysia Jalan Hospital, 93586, Kuching, Sarawak 2- Clinical Research Centre, Kuala Lumpur, Malaysia Hp. No: 0125871220 3- Hospital Sultanah Aminah, Johor Bahru, Johor, Malaysia Email: [email protected] INTRODUCTION Gestational Diabetes is common in Malaysia and has significant maternal and fetal implications. Active intervention has shown to improve pregnancy outcomes. Pregnancy is an opportunistic time for screening as the future implications of Diabetes can be significant. An ideal screening tool should not be based on complications of the disease or following an adverse event. Despite recommendations for universal screening in a high risk population, Malaysia has opted for selective screening, due to concerns with cost and resources. The objective is to review the effectiveness of the current practice of selective screening for GDM in Malaysia. METHODOLOGY This is a retrospective cohort study. The study period was from 1st January 2011 till 31st December 2012 and 22, 044 patients with GDM were analyzed. Specific variables were extracted from the National Obstetric Registry of Malaysia from all the participating hospitals, with a total 260,959 patients. RESULTS The incidence of GDM is 8.4%. Majority of these patients were identified following GDM complications such as fetal macrosomia, polyhydramnios or increased weight gain. GESTATIONAL DIABETES CRUDE OR VARIABLE YES NO (SIMPLE -
Supranuclear and Internuclear Ocular Motility Disorders
CHAPTER 19 Supranuclear and Internuclear Ocular Motility Disorders David S. Zee and David Newman-Toker OCULAR MOTOR SYNDROMES CAUSED BY LESIONS IN OCULAR MOTOR SYNDROMES CAUSED BY LESIONS OF THE MEDULLA THE SUPERIOR COLLICULUS Wallenberg’s Syndrome (Lateral Medullary Infarction) OCULAR MOTOR SYNDROMES CAUSED BY LESIONS OF Syndrome of the Anterior Inferior Cerebellar Artery THE THALAMUS Skew Deviation and the Ocular Tilt Reaction OCULAR MOTOR ABNORMALITIES AND DISEASES OF THE OCULAR MOTOR SYNDROMES CAUSED BY LESIONS IN BASAL GANGLIA THE CEREBELLUM Parkinson’s Disease Location of Lesions and Their Manifestations Huntington’s Disease Etiologies Other Diseases of Basal Ganglia OCULAR MOTOR SYNDROMES CAUSED BY LESIONS IN OCULAR MOTOR SYNDROMES CAUSED BY LESIONS IN THE PONS THE CEREBRAL HEMISPHERES Lesions of the Internuclear System: Internuclear Acute Lesions Ophthalmoplegia Persistent Deficits Caused by Large Unilateral Lesions Lesions of the Abducens Nucleus Focal Lesions Lesions of the Paramedian Pontine Reticular Formation Ocular Motor Apraxia Combined Unilateral Conjugate Gaze Palsy and Internuclear Abnormal Eye Movements and Dementia Ophthalmoplegia (One-and-a-Half Syndrome) Ocular Motor Manifestations of Seizures Slow Saccades from Pontine Lesions Eye Movements in Stupor and Coma Saccadic Oscillations from Pontine Lesions OCULAR MOTOR DYSFUNCTION AND MULTIPLE OCULAR MOTOR SYNDROMES CAUSED BY LESIONS IN SCLEROSIS THE MESENCEPHALON OCULAR MOTOR MANIFESTATIONS OF SOME METABOLIC Sites and Manifestations of Lesions DISORDERS Neurologic Disorders that Primarily Affect the Mesencephalon EFFECTS OF DRUGS ON EYE MOVEMENTS In this chapter, we survey clinicopathologic correlations proach, although we also discuss certain metabolic, infec- for supranuclear ocular motor disorders. The presentation tious, degenerative, and inflammatory diseases in which su- follows the schema of the 1999 text by Leigh and Zee (1), pranuclear and internuclear disorders of eye movements are and the material in this chapter is intended to complement prominent. -
The Provider-Based Evaluation (Probe) 2014 Preliminary Report
The Provider-Based Evaluation (ProBE) 2014 Preliminary Report I. Background of ProBE 2014 The Provider-Based Evaluation (ProBE), continuation of the formerly known Malaysia Government Portals and Websites Assessment (MGPWA), has been concluded for the assessment year of 2014. As mandated by the Government of Malaysia via the Flagship Coordination Committee (FCC) Meeting chaired by the Secretary General of Malaysia, MDeC hereby announces the result of ProBE 2014. Effective Date and Implementation The assessment year for ProBE 2014 has commenced on the 1 st of July 2014 following the announcement of the criteria and its methodology to all agencies. A total of 1086 Government websites from twenty four Ministries and thirteen states were identified for assessment. Methodology In line with the continuous and heightened effort from the Government to enhance delivery of services to the citizens, significant advancements were introduced to the criteria and methodology of assessment for ProBE 2014 exercise. The year 2014 spearheaded the introduction and implementation of self-assessment methodology where all agencies were required to assess their own websites based on the prescribed ProBE criteria. The key features of the methodology are as follows: ● Agencies are required to conduct assessment of their respective websites throughout the year; ● Parents agencies played a vital role in monitoring as well as approving their agencies to be able to conduct the self-assessment; ● During the self-assessment process, each agency is required to record -
Retina and Neuro Ophthalmology
Name : …………………………………………………………… Roll No. : ………………………………………………………… Invigilator's Signature : ……………………………………….. CS/B.OPTM/SEM-5/BO-504/2010-11 2010-11 OCULAR DISEASE - II POSTERIOR SEGMENT ( RETINA & NEURO-OPHTHALMOLOGY ) Time Allotted : 3 Hours Full Marks : 70 The figures in the margin indicate full marks. Candidates are required to give their answers in their own words as far as practicable. GROUP – A ( Multiple Choice Type Questions ) 1. Choose the correct alternatives for any ten of the following : 10 × 1 = 10 i) Which is not an important diagnostic criterion of giant cell arteritis ? http://www.makaut.com/ a) ESR > 70 mm/hour b) C-reactive protein > 2·45 mg/dl c) Jaw caludication d) Neck pain. ii) Unilateral blindness in a male child with massive exudation under the retina is most likely a case of a) Coat's disease b) Retinoblastoma c) Sturge-Weber syndrome d) Louis-Bar's syndrome. 5323 [ Turn over http://www.makaut.com/ CS/B.OPTM/SEM-5/BO-504/2010-11 iii) A retinal detachment patient mostly complains of a) pain b) good vision c) flashes and floaters d) diplopia. iv) In myasthenia gravis, during a diagnostic test, we use a drug called a) Piperazine citrate b) Azathioprim c) Edrophonium d) Carbamazepine. v) Sillicone oil is a/an a) aqueous substitute b) lens substitute c) vitreous substitute d) artificial lens. vi) In retinoblastoma, if the microscopical examination shows Flexner-Wintersteiner rosettes, it is considered to be a) highly malignant b) less malignant c) not malignant d) none of these. vii) Dyschromatopsia is the term for defective a) day vision b) night vision http://www.makaut.com/ c) colour vision d) light brightness sensitivity. -
A Case of Multiple Sclerosis Presenting As Eight and Half Syndrome
Online Journal of Health and Allied Sciences Peer Reviewed, Open Access, Free Online Journal Published Quarterly : Mangalore, South India : ISSN 0972-5997 This work is licensed under a Volume 11, Issue 4; Oct-Dec 2012 Creative Commons Attribution- No Derivative Works 2.5 India License Case Report: A Case of Multiple Sclerosis Presenting as Eight and Half Syndrome. Authors Rajiv Raina, Professor, Madan Kaushik, Assistant Professor, Sanjay K Mahajan, Assistant Professor, Sushil Raghav, Senior Resident, Sharathbabu NM, Junior Resident, Dept. of Medicine, Indira Gandhi Medical College, Shimla. Address for Correspondence Dr. Sharathbabu NM, Junior Resident, Dept. of Medicine, Indira Gandhi Medical College, Shimla, India. E-mail: [email protected] Citation Raina R, Kaushik M, Mahajan SK, Raghav S, Sharathbabu NM. A Case of Multiple Sclerosis Presenting as Eight and Half Syndrome. Online J Health Allied Scs. 2012;11(4):15. Available at URL: http://www.ojhas.org/issue44/2012-4-15.html Open Access Archives http://cogprints.org/view/subjects/OJHAS.html http://openmed.nic.in/view/subjects/ojhas.html Submitted: Dec 5, 2012; Accepted: Jan 7, 2013; Published: Jan 25, 2013 Abstract: Multiple sclerosis (MS) is a chronic disease spinal cord. MRI showed hyperintensities on T2 weighted characterized by inflammation, demyelination, gliosis images oriented perpendicular to the ventricular surface, (scarring), and neuronal loss; the course can be relapsing- corresponding to the pathologic pattern of perivenous remitting or progressive. Manifestations of MS vary from a demyelination (Dawson's fingers) and hyperintensities in the benign illness to a rapidly evolving and incapacitating dorsal tegmentum of caudal pons(Fig. 3a & 3b). Patient was disease requiring profound lifestyle adjustments. -
Auditor General's Report 2015
AUDITOR GENERAL’S REPORT 2015 NATIONAL AUDIT DEPARTMENT MALAYSIA GOVERNMENT’S FINANCIAL STATEMENT, FINANCIAL MANAGEMENT No. 15, Level 1-5 FOR THE YEAR 2015 AND ACTIVITIES OF THE Persiaran Perdana, Presint 2 Pusat Pentadbiran Kerajaan Persekutuan FEDERAL MINISTRIES/DEPARTMENTS AND 62518 Putrajaya MANAGEMENT OF THE GOVERNMENT’S COMPANIES www.audit.gov.my SERIES 1 NATIONAL AUDIT DEPARTMENT MALAYSIA WJHS00124 Cover.indd 1 WJHS00124 T.page.indd 11 5/13/165/13/16 3:354:18 PMPM SYNOPSIS AUDITOR GENERAL’S REPORT FOR THE YEAR 2015 THE AUDIT OF THE FEDERAL GOVERNMENT’S FINANCIAL STATEMENT, FINANCIAL MANAGEMENT, ACTIVITIES OF THE FEDERAL MINISTRIES/DEPARTMENTS AND MANAGEMENT OF THE GOVERNMENT COMPANIES NATIONAL AUDIT DEPARTMENT MALAYSIA i WJHS00124 T.page.indd 1 5/13/16 2:53 PM CONTENTS iii WJHS00124 T.page.indd 2 5/13/16 2:53 PM CONTENTS iii WJHS00124 T.page.indd 3 5/13/16 2:53 PM CONTENTS PAGE CONTENTS v SECTION I THE FEDERAL GOVERNMENT’S FINANCIAL STATEMENT AND FINANCIAL MANAGEMENT OF THE FEDERAL MINISTRIES/DEPARTMENTS PREFACE 5 SYNOPSIS 13 PART I CERTIFICATION OF THE FEDERAL GOVERNMENT‟S FINANCIAL STATEMENT FOR THE YEAR ENDED 31ST DECEMBER 2015 1. Certification Of The Federal Government‟s Financial Statement For The Year Ended 31st December 2015 15 PART II FINANCIAL MANAGEMENT OF THE FEDERAL GOVERNMENT 2. Overall Financial Management Performance 15 3. Financial Management Of The Federal Ministries And Departments 16 4. Public Accounts Committee Meeting 17 CONCLUSION 19 v WJHS00124 T.page.indd 4 5/13/16 2:53 PM CONTENTS PAGE CONTENTS v SECTION I THE FEDERAL GOVERNMENT’S FINANCIAL STATEMENT AND FINANCIAL MANAGEMENT OF THE FEDERAL MINISTRIES/DEPARTMENTS PREFACE 5 SYNOPSIS 13 PART I CERTIFICATION OF THE FEDERAL GOVERNMENT‟S FINANCIAL STATEMENT FOR THE YEAR ENDED 31ST DECEMBER 2015 1. -
Covid-19) Situation in Malaysia
PRESS STATEMENT MINISTRY OF HEALTH MALAYSIA UPDATES ON THE CORONAVIRUS DISEASE 2019 (COVID-19) SITUATION IN MALAYSIA Current Status of Confirmed COVID-19 Cases Who Have Recovered 30 April 2020 – The Ministry of Health (MOH) would like to inform that 84 cases have fully recovered and discharged well today. Cumulatively, 4,171 confirmed COVID-19 cases have fully recovered and discharged well (69.5% of total cumulative cases). Current Situation of COVID-19 in Malaysia 30 April 2020, 12 pm – A total of 57 additional confirmed COVID-19 cases were reported to the National Crisis Preparedness and Response Centre (CPRC) MOH today. Cumulatively there are now 6,002 confirmed COVID-19 cases in Malaysia. Therefore, there are currently 1,729 active and infective COVID-19 cases. They have been isolated and provided treatment. Of these 57 additional cases reported today, 25 are imported cases. The remaining 32 cases are due to local transmission. Currently, 36 confirmed COVID-19 cases are receiving treatment in intensive care units (ICU), and of these, 14 cases are on ventilation support. Regretfully, two (2) additional COVID-19 deaths were reported to the National CPRC MOH today. Cumulatively, there are now 102 COVID-19 deaths in Malaysia (1.7% of total cumulative cases): 1. Death #101: Case 4,657 is a 64 year-old Malaysian man with a history of haematological cancer. He was a close contact to a confirmed COVID-19 case (Case 4,476; from the Bali PUI cluster). He was admitted into Tengku Ampuan Afzan Hospital, Pahang on 12 April 2020 and was pronounced dead on 29 April 2020 at 4.14 pm. -
Malaysia Health System Review Health Systems in Transition Vol
Health Systems in Transition Vol. 2 No. 1 2012 Vol. in Transition Health Systems Health Systems in Transition Vol. 3 No.1 2013 Malaysia Health System Review The Asia Pacific Observatory on Health Review Malaysia Health System Systems and Policies is a collaborative partnership which supports and promotes evidence-based health policy making in the Asia Pacific Region. Based in WHO’s Regional Office for the Western Pacific it brings together governments, international agencies, foundations, civil society and the research community with the aim of linking systematic and scientific analysis of health systems in the Asia Pacific Region with the decision- makers who shape policy and practice. Asia Pacific Observatory on Health Systems and Policies Health Systems in Transition Vol. 3 No. 1 2013 Malaysia Health System Review Written by: Safurah Jaafar, Ministry of Health, Malaysia Kamaliah Mohd Noh, Ministry of Health, Malaysia Khairiyah Abdul Muttalib, Ministry of Health, Malaysia Nour Hanah Othman, Ministry of Health, Malaysia Judith Healy, Australian National University, Australia Other authors: Kalsom Maskon, Ministry of Health, Malaysia Abdul Rahim Abdullah, Ministry of Health, Malaysia Jameela Zainuddin, Ministry of Health, Malaysia Azman Abu Bakar, Ministry of Health, Malaysia Sameerah Shaikh Abd Rahman, Ministry of Health, Malaysia Fatanah Ismail, Ministry of Health, Malaysia Chew Yoke Yuen, Ministry of Health, Malaysia Nooraini Baba, Ministry of Health, Malaysia Zakiah Mohd Said, Ministry of Health, Malaysia Edited by: Judith Healy, Australian National University, Australia WHO Library Cataloguing in Publication Data Malaysia health system review. (Health Systems in Transition, Vol. 2 No. 1 2012) 1. Delivery of healthcare. 2. Health care economics and organization. -
Malaysian Statistics on Medicines 2009 & 2010
MALAYSIAN STATISTICS ON MEDICINES 2009 & 2010 Edited by: Siti Fauziah A., Kamarudin A., Nik Nor Aklima N.O. With contributions from: Faridah Aryani MY., Fatimah AR., Sivasampu S., Rosliza L., Rosaida M.S., Kiew K.K., Tee H.P., Ooi B.P., Ooi E.T., Ghan S.L., Sugendiren S., Ang S.Y., Muhammad Radzi A.H. , Masni M., Muhammad Yazid J., Nurkhodrulnada M.L., Letchumanan G.R.R., Fuziah M.Z., Yong S.L., Mohamed Noor R., Daphne G., Chang K.M., Tan S.M., Sinari S., Lim Y.S., Tan H.J., Goh A.S., Wong S.P., Fong AYY., Zoriah A, Omar I., Amin AN., Lim CTY, Feisul Idzwan M., Azahari R., Khoo E.M., Bavanandan S., Sani Y., Wan Azman W.A., Yusoff M.R., Kasim S., Kong S.H., Haarathi C., Nirmala J., Sim K.H., Azura M.A., Suganthi T., Chan L.C., Choon S.E., Chang S.Y., Roshidah B., Ravindran J., Nik Mohd Nasri N.I, Wan Hamilton W.H., Zaridah S., Maisarah A.H., Rohan Malek J., Selvalingam S., Lei C.M., Hazimah H., Zanariah H., Hong Y.H.J., Chan Y.Y., Lin S.N., Sim L.H., Leong K.N., Norhayati N.H.S, Sameerah S.A.R, Rahela A.K., Yuzlina M.Y., Hafizah ZA ., Myat SK., Wan Nazuha W.R, Lim YS,Wong H.S., Rosnawati Y., Ong S.G., Mohd. Shahrir M.S., Hussein H., Mary S.C., Marzida M., Choo Y. M., Nadia A.R., Sapiah S., Mohd. Sufian A., Tan R.Y.L., Norsima Nazifah S., Nurul Faezah M.Y., Raymond A.A., Md. -
Eyes and Stroke: the Visual Aspects of Cerebrovascular Disease
Open Access Review Stroke Vasc Neurol: first published as 10.1136/svn-2017-000079 on 6 July 2017. Downloaded from Eyes and stroke: the visual aspects of cerebrovascular disease John H Pula,1 Carlen A Yuen2 To cite: Pula JH, Yuen CA. Eyes ABSTRACT to the LGBs,1 5 6 the terminal anastomosis is and stroke: the visual aspects of A large portion of the central nervous system is dedicated vulnerable to ischaemia.7 Optic radiations cerebrovascular disease. Stroke to vision and therefore strokes have a high likelihood 2017; : originate from the lateral geniculate nucleus and Vascular Neurology 2 of involving vision in some way. Vision loss can be the e000079. doi:10.1136/svn- (LGN) and are divided into superior, inferior, 2017-000079 most disabling residual effect after a cerebral infarction. and central nerve fibres. The optic radiations Transient vision problems can likewise be a harbinger of are predominantly supplied by the posterior stroke and prompt evaluation after recognition of visual and middle cerebral arteries1 and the AChA.6 Received 12 March 2017 symptoms can prevent future vascular injury. In this review, Inferior fibres, known as Meyer’s Loop,6 travel Revised 30 May 2017 we discuss the visual aspects of stroke. First, anatomy and Accepted 2 June 2017 the vascular supply of the visual system are considered. to the temporal lobe, while the superior and Published Online First Then, the different stroke syndromes which involve vision central nerve fibre bundles travel to the pari- 6 July 2017 1 are discussed. Finally, topics involving the assessment, etal lobes. The termination of optic radia- prognosis, treatment and therapeutic intervention of vision- tions is located in the visual striate cortex (V1) specific stroke topics are reviewed.